Chronic inflammatory skin diseases: From pathogenesis to treatment
Significant progress has been achieved in the last few decades in dermatology, especially regarding chronic inflammatory skin diseases. In recent years, great progress has also been made in understanding the pathogenesis of the most common inflammatory skin diseases such as psoriasis, atopic dermatitis, and hidradenitis suppurativa that has led to the development of selective and targeted innovative therapies. In particular, biological drugs (chimeric, humanized, and fully human monoclonal antibodies), biosimilars, and small molecules have completely revolutionized the treatment of chronic inflammatory skin diseases by opening new avenues for clinicians. However, significant research efforts are still needed. New studies are needed to identify biomarkers for each disease, so that clinicians may be able to diagnose and treat chronic inflammatory diseases early and predict responses to treatments so that we can choose the best treatment for each type of patient. All article types, including case reports, case series, original research articles, and review articles, are in line with the scope of this Article Collection. This Collection welcomes submissions covering a range of related areas of chronic inflammatory skin diseases, including psoriasis, atopic dermatitis, hidradenitis suppurativa, alopecia areata and others. Keywords: Psoriasis; Hidradenitis Suppurativa; Atopic dermatitis; Alopecia areata; Skin inflammatory disease
Guest advisors
Fabrizio Martora(University of Naples Federico II, Italy)
Matteo Megna(University of Naples Federico II, Italy)
Teresa Battista(University of Naples Federico II, Italy)